This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Original Articles

A Randomized Controlled Study of Sequentially Applied Repetitive Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder

Jee In Kang, MD; Chan-Hyung Kim, MD; Kee Namkoong, MD; Chang-il Lee, MD; and Se Joo Kim, MD

Published: August 25, 2009

Article Abstract

Objective: The present study investigated possible therapeutic effects and safety of sequentially combined low-frequency repetitive transcranial magnetic stimulation (rTMS) to the right dorsolateral prefrontal cortex and supplementary motor area in patients with treatment-resistant obsessive-compulsive disorder.

Method: Between February 2007 and January 2008, we carried out a study with a rater-blinded, sham-controlled design in which 20 patients with treatment-resistant obsessive-compulsive disorder, confirmed by a psychiatrist after use of the Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version, were randomly assigned to either active rTMS (n‘ ‰=‘ ‰10) or sham treatment (n‘ ‰=‘ ‰10). Over 10 days, rTMS of 1 Hz was given at 110% of the motor threshold for 20 minutes over the right dorsolateral prefrontal cortex and sequentially at 1 Hz at 100% of the motor threshold for 20 minutes over the supplementary motor area. The primary outcome measure was the Yale-Brown Obsessive Compulsive Scale (YBOCS) score.

Results: For the between-group analyses, there were no significant differences over 4 weeks between the active and sham groups on the YBOCS (F‘ ‰=‘ ‰0.01, P‘ ‰=‘ ‰.92) and the Montgomery-Asberg Depression Rating Scale (MADRS; F‘ ‰=‘ ‰0.39, P‘ ‰=‘ ‰.54). In repeated-measures analyses on all subjects, there was a significant effect of time on the YBOCS (F‘ ‰=‘ ‰5.48, P‘ ‰=‘ ‰.009) and the MADRS (F‘ ‰=‘ ‰6.55, P‘ ‰=‘ ‰.004). There were no significant group-by-time interactions for the YBOCS (F‘ ‰=‘ ‰0.03, P‘ ‰=‘ ‰.94) or the MADRS (F‘ ‰=‘ ‰0.09, P‘ ‰=‘ ‰.67).

Conclusions: These findings suggest that 10 sessions of sequential rTMS of the right dorsolateral prefrontal cortex and the supplementary motor area at low frequency had no therapeutic effect on obsessive-compulsive symptoms. However, rTMS was a safe method of treatment, and there was no significant change in cognitive function after rTMS. Further controlled studies using a more sophisticated sham system in larger samples are required to confirm the effect of rTMS in obsessive-compulsive disorder.

Trial Registration: clinicaltrials.gov Identifier: NCT00932204

Submitted: June 28, 2008; accepted November 3, 2008.

Online ahead of print: August 25, 2009.

Corresponding author: Se Joo Kim, MD, Department of Psychiatry and Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, 134 Sinchon-dong, Seodaemun-gu, Seoul 120-752, Republic of Korea (kimsejoo@yuhs.ac).

Volume: 70

Quick Links: Obsessive-Compulsive and Related Disorders

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...